Skip to content
Lower risk Drug recall · FDA · Published January 12, 2024

IntegraDose Vasopressin Recall: Subpotent Drug Risk

IntegraDose recalls Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride with subpotent drug risk. Affected units have NDC 71139-0190-1, lot 20230921VAS-2, expiring 03/19/2024.

🇺🇸 FDA recall #D-0258-2024DrugIntegraDose ›
Take action

Contact the company

Recalling firmIntegraDose Compounding Services LLC719 Kasota Ave Se · Minneapolis, MN 55414-2842
✎ GovInfoNow plain-language explainer

IntegraDose is recalling Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride due to a subpotent drug hazard. This means the medication may not work as intended when used as prescribed, potentially leading to ineffective treatment. Read more at govinfonow.com/recall/32883-integradose-vasopressin-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32883-integradose-vasopressin-recall-subpotent-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0258-2024

Cite this page

“IntegraDose Vasopressin Recall: Subpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32883-integradose-vasopressin-recall-subpotent-drug-risk. Based on FDA recall #D-0258-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0258-2024%22&limit=1).

The FDA announced on Jan. 12, 2024, that IntegraDose Compounding Services LLC is recalling Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride due to subpotent drug risks. The voluntary Class II recall affects 281 syringes distributed only in Minnesota.

How to tell if you have it

  • Brand: IntegraDose
  • Product: Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only
  • NDC: 71139-0190-1
  • Lot #: 20230921VAS-2
  • Exp. Date: 03/19/2024
  • Quantity: 281 syringes
  • Distribution: MN only

The hazard

The product is classified as a subpotent drug, meaning it may not contain the labeled amount of active ingredient. The FDA recorded this hazard for the recalled lot.

Context

GovInfoNow's records show IntegraDose Compounding Services LLC has 6 other recalls on record since Sept. 17, 2021. Other recent recalls of similar products include IntegraDose Vasopressin 2 Units/2mL Recall (May 18, 2026), IntegraDose Fentanyl Citrate Recall (May 12, 2026), and IntegraDose Oxytocin IV Solution Recall (Sept. 16, 2025). Other recent recalls of similar products include ImprimisRx Povidone Iodine Ophthalmic Solution Recall (Aug. 24, 2026), Baxter Vasopressin Injection Recall (Aug. 6, 2026), and Gasco Isopropyl Alcohol 70% Recall (May 29, 2026).

How to tell if you have this one

Check for the NDC number 71139-0190-1 on the product label. The lot number is 20230921VAS-2 and the expiration date is March 19, 2024.

  • Brand
    IntegraDose
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC number 71139-0190-1 and lot number 20230921VAS-2 on the product label.

Where it went and when

Where it was distributed

Distributed in Minnesota.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “MN only” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Minnesota.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Jan 12, 202412. FDA classified it Class II: Jan 22, 202423. Published in FDA’s Enforcement Report: Jan 31, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0258-2024 (January 12, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0258-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA